Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
PrECOG, LLC.
PrECOG, LLC.
Guangdong Provincial People's Hospital
Abramson Cancer Center at Penn Medicine
University of Washington
Sichuan University
Sichuan University
University Hospital, Essen
Trans Tasman Radiation Oncology Group
Sun Yat-sen University
University of Kentucky
Tang-Du Hospital
Capital Medical University
Shanghai Pulmonary Hospital, Shanghai, China
Sun Yat-sen University
Institut Paoli-Calmettes
Swiss Cancer Institute
The First Hospital of Jilin University
Shanghai University of Traditional Chinese Medicine
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Sykehuset i Vestfold HF
Abramson Cancer Center at Penn Medicine
H. Lee Moffitt Cancer Center and Research Institute
Ain Shams University
The First People's Hospital of Lianyungang
Roswell Park Cancer Institute
Centre Francois Baclesse
Shanghai University of Traditional Chinese Medicine
Alliance for Clinical Trials in Oncology
University of Chicago
Roswell Park Cancer Institute